Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

[Results of percutaneous cryoablation for malignant lung tumors compared with radiotherapy].

Yamauchi Y, Kawamura M, Inoue M, Yashiro H, Nakatsuka S.

Kyobu Geka. 2014 Jul;67(8):747-52. Japanese.

PMID:
25138950
2.

Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.

Yamauchi Y, Izumi Y, Hashimoto K, Yashiro H, Inoue M, Nakatsuka S, Goto T, Anraku M, Ohtsuka T, Kohno M, Kawamura M, Nomori H.

PLoS One. 2012;7(3):e33223. doi: 10.1371/journal.pone.0033223. Epub 2012 Mar 8.

3.

Percutaneous cryoablation for inoperable malignant lung tumors: midterm results.

Chou HP, Chen CK, Shen SH, Sheu MH, Wu MH, Wu YC, Chang CY.

Cryobiology. 2015 Feb;70(1):60-5. doi: 10.1016/j.cryobiol.2014.12.004. Epub 2014 Dec 23.

PMID:
25541142
4.

CT-guided thin needles percutaneous cryoablation (PCA) in patients with primary and secondary lung tumors: a preliminary experience.

Pusceddu C, Sotgia B, Fele RM, Melis L.

Eur J Radiol. 2013 May;82(5):e246-53. doi: 10.1016/j.ejrad.2012.12.010. Epub 2013 Feb 8.

PMID:
23394762
5.

Factors affecting local progression after percutaneous cryoablation of lung tumors.

Yashiro H, Nakatsuka S, Inoue M, Kawamura M, Tsukada N, Asakura K, Yamauchi Y, Hashimoto K, Kuribayashi S.

J Vasc Interv Radiol. 2013 Jun;24(6):813-21. doi: 10.1016/j.jvir.2012.12.026. Epub 2013 Feb 28.

PMID:
23453538
6.

Percutaneous cryoablation of pulmonary metastases from colorectal cancer.

Yamauchi Y, Izumi Y, Kawamura M, Nakatsuka S, Yashiro H, Tsukada N, Inoue M, Asakura K, Nomori H.

PLoS One. 2011;6(11):e27086. doi: 10.1371/journal.pone.0027086. Epub 2011 Nov 9.

7.

Percutaneous cryoablation of lung tumors: feasibility and safety.

Inoue M, Nakatsuka S, Yashiro H, Ito N, Izumi Y, Yamauchi Y, Hashimoto K, Asakura K, Tsukada N, Kawamura M, Nomori H, Kuribayashi S.

J Vasc Interv Radiol. 2012 Mar;23(3):295-302; quiz 305. doi: 10.1016/j.jvir.2011.11.019. Epub 2012 Jan 20.

PMID:
22265246
8.

[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.

Cancer Radiother. 2013 Jul-Aug;17(4):272-81. doi: 10.1016/j.canrad.2013.01.021. Epub 2013 May 24. French.

PMID:
23712043
9.

Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.

Lee DS, Kim YS, Yoo IeR, Kang YN, Kim SJ, Oh JK, Kim YK, Wang YP, Park JG, Kang JH, Han DH, Ahn MI, Lee KY.

Lung Cancer. 2013 May;80(2):172-8. doi: 10.1016/j.lungcan.2012.12.023. Epub 2013 Feb 8.

PMID:
23489556
10.

Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events.

Inoue T, Oh RJ, Shiomi H, Masai N, Miura H.

Strahlenther Onkol. 2013 Apr;189(4):285-92. doi: 10.1007/s00066-012-0290-1. Epub 2013 Feb 20.

PMID:
23420546
11.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
12.

Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.

Morgan MA, Roberts NR, Pino LA, Trabulsi EJ, Brown DB, Gomella LG, Lallas CD.

Can J Urol. 2013 Oct;20(5):6933-7.

PMID:
24128832
13.

Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.

Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):117-25. Epub 2006 Jun 9.

PMID:
16765528
14.

Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.

van der Voort van Zyp NC, Prévost JB, Hoogeman MS, Praag J, van der Holt B, Levendag PC, van Klaveren RJ, Pattynama P, Nuyttens JJ.

Radiother Oncol. 2009 Jun;91(3):296-300. doi: 10.1016/j.radonc.2009.02.011. Epub 2009 Mar 16.

PMID:
19297048
15.

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.

Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.

Clin Lung Cancer. 2008 Jul;9(4):217-21. doi: 10.3816/CLC.2008.n.032.

PMID:
18650169
16.

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience.

Ohta K, Shimohira M, Iwata H, Hashizume T, Ogino H, Miyakawa A, Murai T, Shibamoto Y.

J Radiat Res. 2013 Sep;54(5):957-61. doi: 10.1093/jrr/rrt020. Epub 2013 Apr 21.

17.

CT-guided percutaneous cryoablation of central lung tumors.

Colak E, Tatlı S, Shyn PB, Tuncalı K, Silverman SG.

Diagn Interv Radiol. 2014 Jul-Aug;20(4):316-22. doi: 10.5152/dir.2014.13440.

18.

Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.

Fukumoto S, Shirato H, Shimzu S, Ogura S, Onimaru R, Kitamura K, Yamazaki K, Miyasaka K, Nishimura M, Dosaka-Akita H.

Cancer. 2002 Oct 1;95(7):1546-53.

19.

CyberKnife radiosurgery for stage I lung cancer: results at 36 months.

Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.

Clin Lung Cancer. 2007 Sep;8(8):488-92.

PMID:
17922973
20.

Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.

Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, Zhang Y, Subramaniam D, Reichner CA, Sarikaya I, Esposito G, Yousefi S, Jamis-Dow C, Banovac F, Anderson ED.

J Hematol Oncol. 2009 Jan 17;2:1. doi: 10.1186/1756-8722-2-1.

Supplemental Content

Support Center